Coronavirus: Russia ready to trial combined AstraZeneca, Sputnik V vaccine in Ukraine

Published: Updated:
Enable Read mode
100% Font Size

Russia is ready to conduct clinical trials in Ukraine of a COVID-19 vaccine combining its Sputnik V with a vaccine developed by AstraZeneca together with Oxford University, the head of Russian Direct Investment Fund (RDIF) said on Saturday.

Russia’s sovereign RDIF, which is marketing the Sputnik V vaccine abroad, announced in December trials to test a combination of the AstraZeneca vaccine with the Sputnik V shot to see if this can boost the efficacy of the British drugmaker’s vaccine.


Visit our dedicated coronavirus site here for all the latest updates.

Russia reported 26,301 coronavirus cases over the past 24 hours, the country’s anti-coronavirus crisis center said on Saturday.

The new cases bring Russia's tally of confirmed COVID-19 cases up to 3,212,637, state news agency TASS reported.

For all the latest headlines follow our Google News channel online or via the app.

In another development, Britain will allow people to be given shots of different COVID-19 vaccines on rare occasions, despite a lack of evidence about the extent of immunity offered by mixing doses.

In a departure from other strategies globally, the government said people could be given a mix-and-match of two COVID-19 shots, for example if the same vaccine dose was out of stock, according to guidelines published on New Year’s Eve.

Read more:

Coronavirus: Russia inoculates over 800,000 people, issues vaccination certificates

Russia can develop vaccine against any new coronavirus mutated strain: Top scientist

Top Content Trending